BACKGROUND: This study compared peritoneal dialysis (PD) and hemodialysis (HD) outcomes between female systemic lupus erythematosus (SLE) patients with end-stage renal disease (ESRD) due to lupus nephropathy. METHODS: 22 female SLE patients undergoing PD were compared with 14 female SLE patients receiving HD. Clinical outcomes and infective complications were reviewed. RESULTS: The overall mortality rate was much higher in the PD group (6/22) than in the HD group (1/14) (p = 0.027). PD patients had higher C-reactive protein level (37.1 +/- 41.4 vs. 6.7 +/- 9.5 mg/l, p = 0.037) and numbers of infectious episode (PD vs. HD: 1 episode per 33.16 patient-months vs. 1 episode per 118.26 patient-months, respectively, p = 0.046). Before the end of the observation period, HD patients had higher serum albumin (3.8 +/- 0.2 vs. 3.3 +/- 0.6 g/dl, p = 0.01). CONCLUSIONS: In female SLE patients with ESRD due to lupus nephropathy, clinical outcomes are better after undergoing HD than after undergoing PD. Copyright 2009 S. Karger AG, Basel.
BACKGROUND: This study compared peritoneal dialysis (PD) and hemodialysis (HD) outcomes between female systemic lupus erythematosus (SLE) patients with end-stage renal disease (ESRD) due to lupus nephropathy. METHODS: 22 female SLEpatients undergoing PD were compared with 14 female SLEpatients receiving HD. Clinical outcomes and infective complications were reviewed. RESULTS: The overall mortality rate was much higher in the PD group (6/22) than in the HD group (1/14) (p = 0.027). PDpatients had higher C-reactive protein level (37.1 +/- 41.4 vs. 6.7 +/- 9.5 mg/l, p = 0.037) and numbers of infectious episode (PD vs. HD: 1 episode per 33.16 patient-months vs. 1 episode per 118.26 patient-months, respectively, p = 0.046). Before the end of the observation period, HDpatients had higher serum albumin (3.8 +/- 0.2 vs. 3.3 +/- 0.6 g/dl, p = 0.01). CONCLUSIONS: In female SLEpatients with ESRD due to lupus nephropathy, clinical outcomes are better after undergoing HD than after undergoing PD. Copyright 2009 S. Karger AG, Basel.
Authors: Amy Devlin; Sushrut S Waikar; Daniel H Solomon; Bing Lu; Tamara Shaykevich; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader Journal: Arthritis Care Res (Hoboken) Date: 2011-12 Impact factor: 4.794
Authors: Gabriel Contreras; Javier Pagan; Ruchir Chokshi; Sharad Virmani; Jorge M Diego; Patricia Byers; Tamara Isakova; Jair Munoz Mendoza; Ali Nayer; Jose Roberto Contreras; Gabriel Panama; Oliver Lenz; Maria Carpintero; Timothy Muchayi; David Roth Journal: Clin J Am Soc Nephrol Date: 2014-09-04 Impact factor: 8.237
Authors: George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas Journal: Ann Rheum Dis Date: 2012-07-31 Impact factor: 19.103